• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Arterial hypertension is a leading cause of death globally. Due to ageing, the rising
incidence of obesity, and socioeconomic and environmental changes, its incidence …

The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of stroke among individuals who have not previously …

The aim of this updated guideline is to provide comprehensive and timely evidence-based
recommendations on the prevention of future stroke among survivors of ischemic stroke or …

Atrial fibrillation (AF) is a cardiac rhythm disorder associated with increased morbidity and
mortality. It is the leading risk factor for cardioembolic stroke and its early detection is crucial …

Background Four new oral anticoagulants compare favourably with warfarin for stroke
prevention in patients with atrial fibrillation; however, the balance between efficacy and …

Atrial fibrillation is found in a third of all ischaemic strokes, even more after post-stroke atrial
fibrillation monitoring. Data from stroke registries show that both unknown and untreated or …

Background Atrial fibrillation is a leading preventable cause of recurrent stroke for which
early detection and treatment are critical. However, paroxysmal atrial fibrillation is often …

Background Among patients with atrial fibrillation, the risk of stroke is highest for those with a
history of stroke; however, oral anticoagulants can lower the risk of recurrent stroke by two …

Background Patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) are at
risk of atrial fibrillation or flutter (AFF) due to cardiac remodeling and kidney complications …